Stem (NYSE:STEM) PT fell to $1.00

Stem (NYSE:STEM – Get a Free Report) The price target was cut by stock analysts at UBS Group from $2.50 to $1.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price objective would indicate a potential upside of 73.25% from the company’s previous close.

STEM has been the subject of several other reports. BMO Capital Markets decreased their price objective on Stem from $2.50 to $1.85 and set a “market perform” rating on the stock in a report on Friday, May 3rd. Goldman Sachs Group reduced their price objective on Stem from $2.50 to $2.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Piper Sandler cut their price objective on Stem from $3.00 to $2.00 and set a “neutral” rating on the stock in a report on Thursday, April 11th. TD Cowen cut Stem from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $4.00 to $1.00 in a report on Wednesday. Finally, Evercore ISI cut their price objective on Stem from $9.00 to $5.00 and set an “outperform” rating on the stock in a report on Wednesday. Ten equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $2.71, according to MarketBeat.com.

Read our latest stock report on STEM

Stem price performance

Shares of NYSE:STEM traded up $0.03 during trading on Thursday, reaching $0.58. 9,780,390 shares of the company traded hands, compared to its average volume of 4,711,392. Stem has a fifty-two week low of $0.53 and a fifty-two week high of $6.70. The company has a quick ratio of 1.61, a current ratio of 1.71, and a debt-to-equity ratio of 1.41. The firm has a market cap of $93.30 million, a PE ratio of -0.40 and a beta of 1.75. The company has a 50-day simple moving average of $1.16 and a 200-day simple moving average of $1.79.

Stem (NYSE:STEM – Get Your Free Report ) last posted its earnings results on Tuesday, August 6th. The company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Stem had a negative return on equity of 40.21% and a negative net margin of 213.33%. The firm had revenue of $34.00 million for the quarter, compared to analysts’ expectations of $64.06 million. During the same period last year, the firm earned ($0.56) EPS. The company’s quarterly revenue was down 63.4% year over year. As a group, analysts forecast that Stem will post -0.72 earnings per share for the current year.

Institutional trading of Stem

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new stake in shares of Stem during the fourth quarter valued at $228,000. SG Americas Securities LLC purchased a new stake in shares of Stem during the fourth quarter valued at $209,000. Rock Point Advisors LLC grew its position in shares of Stem by 104.7% in the fourth quarter. Rock Point Advisors LLC now owns 1,407,525 shares of the company’s stock worth $5,461,000 after acquiring an additional 720,080 shares during the period. KBC Group NV purchased a new stake in shares of Stem during the fourth quarter valued at $170,000. Finally, Ursa Fund Management LLC purchased a new stake in shares of Stem during the fourth quarter valued at $194,000. Hedge funds and other institutional investors own 61.63% of the company’s shares.

About Stem

(Get a free report)

Stem, Inc operates worldwide as a provider of digitally connected, smart and renewable energy storage networks. The company offers energy storage hardware from original equipment manufacturers (OEM); state-of-the-art hardware to assist in site data collection and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which provides battery hardware and software-enabled services to operate energy storage systems.

Read more

Get news and reviews for Stem Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Stem and related companies with MarketBeat.com’s FREE daily email newsletter.